New Delhi:India’s drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.Also Read - Will Develop Booster Shot For New Covid Variant 'Omicron', Says Moderna

This comes after an expert panel of India’s central drug authority recommended granting permission for the restricted use of Bharat Biotech-developed indigenous COVID-19 vaccine Covaxin in an emergency situation, especially in the context of infection by mutant strains. Also Read - WTO Delays Key Meeting Amid COVID Variant Concerns

Also Read - World Races to Contain New COVID Threat; Will Flight Restrictions Help as New Virus Variant Emerges?

Prior to that, the panel had cleared the Serum Institute of India’s emergency use athorisation application for the Oxford-AstraZeneca vaccine Covishield.

Mass roll out of vaccine in coming days

Earlier on Saturday, while speaking to a news channel, AIIMS Chief Dr. Randeep Guleria had said that the mass rollout of COVID-19 vaccine is expected in the coming 10-14 days.

He also stressed on the importance of ensuring crowd management when the vaccination drive finally begins. “We also need to ensure that the vaccines are not getting wasted because of the cold storages. This is why the dry run helps,” News 18 quoted him as saying.

India perhaps the only country with 4 vaccines

Meanwhile, Union minister Prakash Javadekar said that India was probably the only country where four vaccines were in the pipeline– two vaccines in the coming days, while two more are in advance stages of development.

Asked about some religious figures raising doubts over vaccines, Javadekar said, ‘Our vaccine is effective’ and the rest of the world was also using it. He added that vaccines are introduced after tests and those that would be brought in would be safe.

Live Updates

  • 1:58 PM IST

  • 1:58 PM IST

    In the first phase, healthcare workers & frontline workers will be vaccinated. There are three lakh healthcare workers & six lakh frontline workers in Delhi who will be administered with the COVID vaccine: Delhi Health Minister Satyendar Jain

  • 1:58 PM IST

    A watershed moment in India’s famed battle against covid-19 under leadership of PM Modi. Our wait for the vaccine is over with Covishield from Serum Institue of India and Covaxin from Bharat Biotech approved for emergency use in India: Union Health Minister Dr Harsh Vardhan

  • 1:57 PM IST
    Serum Institute of India’s CEO Adar Poonawalla tweeted, Happy new year, everyone! All the risks Serum Institute of India took with stockpiling the vaccine, have finally paid off. COVISHIELD, India’s first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks.
  • 1:57 PM IST

  • 1:57 PM IST

    Drugs regulator approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

  • 11:09 AM IST

    DCGI Clears Covaxin, Covishield Vaccines

  • 11:08 AM IST

    Coronavirus Vaccine LIVE Updates: DCGI begins press conference.